Sarcoma Kaposi

• CLINICAL_TRIALS trial_result · 2022-11-01
  Clinical Trial Update: Pomalidomide for Kaposi Sarcoma in People With or Without HIV [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating pomalidomide for Kaposi sarcoma; study completed with results posted in 2022.

• EMA withdrawal · 2020-07-27
  EMA Application withdrawn: Doxorubicin Hydrochloride Tillomed (doxorubicin hydrochloride) — Laboratorios Tillomed Spain S.L.U

  The EMA withdrew the application for doxorubicin hydrochloride from Laboratorios Tillomed Spain S.L.U. for several cancer indications includ…

• EMA withdrawal · 2010-03-22
  EMA Withdrawn: Paxene (paclitaxel) — Norton Healthcare Ltd.

  Paxene (paclitaxel) is withdrawn from consideration by Norton Healthcare Ltd., affecting indications including sarcoma (Kaposi), non-small c…